Patent Ductus Arteriosus (PDA) – Hemodynamics
Preoperative Hemodynamics
The patent ductus arteriosus (PDA) is a persistent fetal connection between the descending aorta and the pulmonary artery.
- In the postnatal period, systemic pressure exceeds pulmonary arterial pressure, producing a left-to-right shunt (aorta → pulmonary artery).
- This shunt causes increased pulmonary blood flow, which can lead to pulmonary overcirculation and pulmonary hypertension, particularly when the ductus is large.
- The excess flow returns to the left atrium and left ventricle, producing chronic volume overload and chamber enlargement.
- In severe cases, longstanding pulmonary overcirculation increases pulmonary artery pressures, imposing a pressure load on the right ventricle as well.
Postoperative Hemodynamics
Following ligation or device closure of the PDA:
- Pulmonary overcirculation is eliminated, reducing the volume load on the left atrium and ventricle.
- Gradual regression of chamber dilation occurs, and left heart size and function often normalize over time.
- Pulmonary hypertension may improve if closure is performed before irreversible vascular remodeling has occurred.
Clinical Summary
- Before closure: PDA physiology is characterized by a continuous left-to-right shunt leading to left heart volume overload, pulmonary overcirculation, and in severe cases, right heart pressure loading.
- After closure: Hemodynamics improve with relief of volume overload and potential reversal of pulmonary hypertension if intervention is timely.
Additional Considerations
- The clinical presentation depends on ductal size: small PDAs may be asymptomatic, while large PDAs produce heart failure, failure to thrive, or recurrent respiratory infections.
- Eisenmenger physiology can develop if closure is delayed until pulmonary vascular disease becomes fixed, resulting in right-to-left shunting and cyanosis.
- In premature infants, PDA is common due to immaturity of ductal smooth muscle, and management may include medical therapy (indomethacin, ibuprofen) before considering surgical or catheter-based closure.